Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.85 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.61 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1873964 | 0.94 | ALDH1A1 (0.96) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1886706 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1877009 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1879784 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1878344 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1882504 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1878242 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL8113493 | 0.92 | ALDH1A1 (1.00) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1878508 | 0.91 | ALDH1A1 (0.71) | ALDH1A1ENPEPAKR1B1GPR84PPARG | |
| SCHEMBL1880419 | 0.89 | ALDH1A1 (0.75) | ALDH1A1ENPEPAKR1B1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170231979-A1 | Methods and Compositions for Treating Vasomotor Symptoms | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2017-08-17 | — | — | US | claimed |
| US-20140357579-A1 | SYNTHETIC PEPTIDE AMIDES AND DIMERS THEREOF | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD (CH) | 2014-12-04 | — | — | US | claimed |
| US-12404419-B2 | Imide addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| US-12398301-B2 | Adhesives comprising cyclic imide addition-fragmentation and adhesion agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-26 | — | — | US | disclosed |
| US-12329833-B2 | Dental compositions | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250049644-A1 | Dental Compositions | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-02-13 | — | — | US | disclosed |
| US-20250011633-A1 | Adhesives Comprising Cyclic Imide Addition-Fragmentation And Adhesion Agents | 3M INNOVATIVE PROPERTIES COMPANY | 2025-01-09 | — | — | US | disclosed |
| CN-114507366-B | Membranes with hydrophobically modified cellulose fibers and oils | 花王株式会社 | 2024-11-08 | — | — | CN | disclosed |
| EP-4444809-A1 | ADHESIVES COMPRISING CYCLIC IMIDE ADDITION-FRAGMENTATION AND ADHESION AGENTS | 3M Innovative Properties Company (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4444250-A1 | DENTAL COMPOSITIONS | Solventum Intellectual Properties Company (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-118510482-A | Dental composition | 舒万诺知识产权公司 | 2024-08-16 | — | — | CN | disclosed |
| EP-1169382-B1 | WATER-BASED RESIN COMPOSITION | KAO CORP (JP) | 2003-06-04 | — | — | EP | disclosed |
| US-20020183265-A1 | Manufacture and use of an antibiotic/antibiotics preparation | HERAUES KULZER GMBH & CO.KG (DE) | 2002-12-05 | — | — | US | disclosed |
| US-20020182251-A1 | Antibiotic(s) preparation with retarding active ingredient release | HERAUES KULZER GMBH & CO.KG (DE) | 2002-12-05 | — | — | US | disclosed |
| CN-1377384-A | Water-based resin composition | KAO CORP (JP) | 2002-10-30 | — | — | CN | disclosed |
| CN-1376469-A | Slow release antibiotics preparation of bioactive substance | HELLICH GUESA KG (DE) | 2002-10-30 | — | — | CN | disclosed |
| EP-1169382-A1 | WATER-BASED RESIN COMPOSITION | Kao Corporation (JP) | 2002-01-09 | — | — | EP | disclosed |
| WO-2000055247-A1 | WATER-BASED RESIN COMPOSITION | KAO CORPORATION (JP) | 2000-09-21 | — | — | WO | disclosed |
| US-6031019-A | COMPRISING POLYMERS PARTICLES AND AN AMINO ACID OR SALT; PRINTS HAVING EXCELLENT WATERFASTNESS AND IMPROVEMENT IN PRINT DENSITY, INK DISPERSION STABILITY, INK EJECTION STABILITY AND ANTIFOULING (NONVLOGGING) AND WEAR RESISTANCE | KAO CORPORATION (JP) | 2000-02-29 | — | — | US | disclosed |
| US-4997847-A | Thromboxane A2 antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (DE) | 1991-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049644-A1 | Dental Compositions | ARCN1, EEF1D, EBP | ALDH1A1 1021/4885ENPEP 3112/4885AKR1B1 2054/4885 |
| US-12329833-B2 | Dental compositions | ARCN1, EEF1D, EBP | ALDH1A1 1021/4885ENPEP 3112/4885AKR1B1 2054/4885 |
| US-20170231979-A1 | Methods and Compositions for Treating Vasomotor Symptoms | VASP, PDE3A, PDE2A | ALDH1A1 2052/4885ENPEP 2236/4885AKR1B1 869/4885 |
| US-20140357579-A1 | SYNTHETIC PEPTIDE AMIDES AND DIMERS THEREOF | OPRK1, OPRL1, OPRM1 | ALDH1A1 2633/4885ENPEP 171/4885AKR1B1 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.